139 related articles for article (PubMed ID: 10904843)
1. Enteroviral cardiomyopathy: bad news for the dystrophin-glycoprotein complex.
Badorff C; Lee GH; Knowlton KU
Herz; 2000 May; 25(3):227-32. PubMed ID: 10904843
[TBL] [Abstract][Full Text] [Related]
2. Dystrophin disruption in enterovirus-induced myocarditis and dilated cardiomyopathy: from bench to bedside.
Badorff C; Knowlton KU
Med Microbiol Immunol; 2004 May; 193(2-3):121-6. PubMed ID: 12920582
[TBL] [Abstract][Full Text] [Related]
3. Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy.
Badorff C; Lee GH; Lamphear BJ; Martone ME; Campbell KP; Rhoads RE; Knowlton KU
Nat Med; 1999 Mar; 5(3):320-6. PubMed ID: 10086389
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide inhibits dystrophin proteolysis by coxsackieviral protease 2A through S-nitrosylation: A protective mechanism against enteroviral cardiomyopathy.
Badorff C; Fichtlscherer B; Rhoads RE; Zeiher AM; Muelsch A; Dimmeler S; Knowlton KU
Circulation; 2000 Oct; 102(18):2276-81. PubMed ID: 11056105
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Coxsackievirus-associated dystrophin cleavage prevents cardiomyopathy.
Lim BK; Peter AK; Xiong D; Narezkina A; Yung A; Dalton ND; Hwang KK; Yajima T; Chen J; Knowlton KU
J Clin Invest; 2013 Dec; 123(12):5146-51. PubMed ID: 24200690
[TBL] [Abstract][Full Text] [Related]
6. CVB infection and mechanisms of viral cardiomyopathy.
Knowlton KU
Curr Top Microbiol Immunol; 2008; 323():315-35. PubMed ID: 18357777
[TBL] [Abstract][Full Text] [Related]
7. Dissociation of sarcoglycans and the dystrophin carboxyl terminus from the sarcolemma in enteroviral cardiomyopathy.
Lee GH; Badorff C; Knowlton KU
Circ Res; 2000 Sep; 87(6):489-95. PubMed ID: 10988241
[TBL] [Abstract][Full Text] [Related]
8. Enteroviral protease 2A directly cleaves dystrophin and is inhibited by a dystrophin-based substrate analogue.
Badorff C; Berkely N; Mehrotra S; Talhouk JW; Rhoads RE; Knowlton KU
J Biol Chem; 2000 Apr; 275(15):11191-7. PubMed ID: 10753926
[TBL] [Abstract][Full Text] [Related]
9. Clinical severity of viral myocarditis is not associated with a mutation of dystrophin gene cleavage sites.
Lee M; Choi JO; Yun SH; Ju ES; Lee YJ; Kim JW; Lim BK; Jeon ES
Int J Cardiol; 2015 Sep; 194():21-2. PubMed ID: 26011260
[No Abstract] [Full Text] [Related]
10. Low-level expression of a mutant coxsackieviral cDNA induces a myocytopathic effect in culture: an approach to the study of enteroviral persistence in cardiac myocytes.
Wessely R; Henke A; Zell R; Kandolf R; Knowlton KU
Circulation; 1998 Aug; 98(5):450-7. PubMed ID: 9714096
[TBL] [Abstract][Full Text] [Related]
11. Persistent coxsackievirus infection: enterovirus persistence in chronic myocarditis and dilated cardiomyopathy.
Chapman NM; Kim KS
Curr Top Microbiol Immunol; 2008; 323():275-92. PubMed ID: 18357775
[TBL] [Abstract][Full Text] [Related]
12. Enterovirus Persistence in Cardiac Cells of Patients With Idiopathic Dilated Cardiomyopathy Is Linked to 5' Terminal Genomic RNA-Deleted Viral Populations With Viral-Encoded Proteinase Activities.
Bouin A; Gretteau PA; Wehbe M; Renois F; N'Guyen Y; Lévêque N; Vu MN; Tracy S; Chapman NM; Bruneval P; Fornes P; Semler BL; Andreoletti L
Circulation; 2019 May; 139(20):2326-2338. PubMed ID: 30755025
[TBL] [Abstract][Full Text] [Related]
13. Genomic detection of enteroviruses in the myocardium--studies on animal hearts with coxsackievirus B3 myocarditis and endomyocardial biopsies from patients with myocarditis and dilated cardiomyopathy.
Koide H; Kitaura Y; Deguchi H; Ukimura A; Kawamura K; Hirai K
Jpn Circ J; 1992 Oct; 56(10):1081-93. PubMed ID: 1331557
[TBL] [Abstract][Full Text] [Related]
14. Genetics of coxsackievirus B3 cardiovirulence.
Tracy S; Tu Z; Chapman N; Hufnagel G
Eur Heart J; 1995 Dec; 16 Suppl O():15-7. PubMed ID: 8682085
[TBL] [Abstract][Full Text] [Related]
15. Genetics of coxsackievirus B cardiovirulence and inflammatory heart muscle disease.
Tracy S; Chapman NM; Romero J; Ramsingh AI
Trends Microbiol; 1996 May; 4(5):175-9. PubMed ID: 8727596
[TBL] [Abstract][Full Text] [Related]
16. The role of transgenic knockout models in defining the pathogenesis of viral heart disease.
Liu P; Penninger J; Aitken K; Sole M; Mak T
Eur Heart J; 1995 Dec; 16 Suppl O():25-7. PubMed ID: 8682095
[TBL] [Abstract][Full Text] [Related]
17. Molecular pathology and structural features of enteroviral replication. Toward understanding the pathogenesis of viral heart disease.
Klingel K; Selinka HC; Huber M; Sauter M; Leube M; Kandolf R
Herz; 2000 May; 25(3):216-20. PubMed ID: 10904841
[TBL] [Abstract][Full Text] [Related]
18. Characterization of Coxsackie B virus RNA in myocardium from patients with dilated cardiomyopathy by nucleotide sequencing of reverse transcription-nested polymerase chain reaction products.
Archard LC; Khan MA; Soteriou BA; Zhang H; Why HJ; Robinson NM; Richardson PJ
Hum Pathol; 1998 Jun; 29(6):578-84. PubMed ID: 9635677
[TBL] [Abstract][Full Text] [Related]
19. Detection of enteroviral RNA on Guthrie card dried blood of a neonate with fatal Coxsackie B3 myocarditis on day 17.
Smets K; Keymeulen A; Wollants E; Lagrou K; Van Ranst M; Padalko E
J Clin Virol; 2008 Jun; 42(2):207-10. PubMed ID: 18316244
[TBL] [Abstract][Full Text] [Related]
20. A 5' dystrophin duplication mutation causes membrane deficiency of alpha-dystroglycan in a family with X-linked cardiomyopathy.
Bies RD; Maeda M; Roberds SL; Holder E; Bohlmeyer T; Young JB; Campbell KP
J Mol Cell Cardiol; 1997 Dec; 29(12):3175-88. PubMed ID: 9441825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
